Full-Time
Founding Agency Partnerships
Posted on 5/7/2026
Icon
1-10 employees
Digital social business cards with analytics
No salary listed
New York, NY, USA
In Person
 Business & Strategy (1) |
|---|
- Proficient in JavaScript, HTML, and CSS
- Experience with React or Angular frameworks
- Strong understanding of RESTful APIs
- Familiarity with version control systems like Git
- Ability to work in a fast-paced environment
- Develop and maintain web applications
- Collaborate with designers and backend developers
- Participate in code reviews and provide constructive feedback
- Troubleshoot and debug applications
- Stay updated with emerging technologies and industry trends
- Experience with TypeScript
- Knowledge of server-side rendering
- Familiarity with Agile methodologies
- Previous experience in a startup environment
Icon.me builds digital professional cards called Icons that are shared across mobile, email, and online. Icons automatically pull in and display a user’s professional social feeds to create a dynamic profile that highlights industry insights and contact details. Users can see who views, saves, or shares their content through personal analytics, and the system identifies commonalities between connected people to add context to networking. The platform also includes Canvas, a social intranet and company reader for sharing and storing articles and web content among teammates, reducing email clutter and improving content discovery. Compared with typical networking tools, Icon.me ties together external social activity with analytics and personal connection insights while offering a private internal content hub via Canvas. The overall goal is to simplify professional branding and networking, helping individuals and companies share knowledge, manage contacts, and generate leads.
Company Size
1-10
Company Stage
Seed
Total Funding
$9.2M
Headquarters
New York City, New York
Founded
2024
Simplify's Take
What believers are saying
- Admaker 2.0 consolidates eight tools, replacing $10K+/month software stack.
- Creator-consent AI model differentiates from OpenAI's copyright-training approach.
- $500-$50K/month partnership fees with brands create recurring revenue streams.
What critics are saying
- Popl's NFC cards capture leads 3x faster, eroding Icon's lead generation.
- LinkedIn's June 2025 AI profiles replicate social aggregation, slashing user acquisition.
- Slack's February 2026 Canvas channels cannibalize Icon's B2B intranet expansion.
What makes Icon unique
- AI-powered ad creation platform turning single videos into multiple campaign variants.
- Integrated digital business card with social media aggregation and personal analytics.
- Backed by Peter Thiel's Founders Fund and OpenAI, Ramp, Flexport executives.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Icon who can refer or advise you
Benefits
Health Insurance
401(k) Company Match
Remote Work Options
Flexible Work Hours
Unlimited Paid Time Off
Paid Vacation
Mental Health Support
Wellness Program
Gym Membership
Professional Development Budget
Conference Attendance Budget
Company News
Alongside the whitepaper, ICON has launched their new Centre for Obesity that delivers expertise and market intelligence with a ready-to-deploy infrastructure of 100 sites and an in-development database of 10,000 pre-screened patients across the breadth of comorbidities related to obesity.
Dublin, Ireland – 7 May – ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic RD for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that test how a treatment works for more than one condition or disease. As researchers uncover the potential of particular drug classes across interconnected diseases, the commercial opportunities have increased the appetite for additional research that targets multiple indications. The findings indicate that most sponsors (83% of respondents) are pursuing multi-indication approaches in their obesity-related research. However, the survey results also suggest that sponsors may underestimate the complexity of these strategies - particularly when selecting inclusion criteria and endpoints - which can lead to inefficiencies in the clinical development process
After Oxford Outcomes was acquired by ICON Plc. she honed her expertise in real world evidence (RWE), spending a lot of her time on multi-national projects including prospective studies, retrospective database and chart reviews, and eliciting patient, caregiver and provider perspectives.
ICON Public Limited Company (ICLR), a leading healthcare and pharmaceutical services provider, has been hit by a securities fraud class-action lawsuit.
The law firm Kessler Topaz Meltzer & Check, LLP announced on March 16, 2025, that it has filed a securities fraud class action lawsuit against ICON Public Limited Company (ICLR).